The Effectiveness of Cardiac Rehabilitation Programs in Improving Cardiovascular Outcomes: Systematic Review and

Arhum Mahmood1, Rubela Ray2, Shaikh Shams T Bin Salam3

  • 1Internal Medicine, Henry Ford Health System, Detroit, USA.

Cureus
|November 27, 2024
PubMed

Insights

Cardiac rehabilitation (CR) programs significantly reduce cardiovascular disease (CVD) mortality and improve patient function. Implementing these vital secondary prevention programs globally remains a challenge, requiring wider adoption and standardized protocols.

Area of Science:

  • Cardiology
  • Public Health
  • Rehabilitation Medicine

Background:

  • Cardiovascular diseases (CVDs) are leading causes of global mortality and disability.
  • Secondary prevention interventions are crucial for managing CVDs and improving patient outcomes.
  • Cardiac rehabilitation (CR) is recognized as a key component of CVD treatment.

Purpose of the Study:

  • To systematically review and meta-analyze the impact of CR on mortality, morbidity, functional capacity, and quality of life in CVD patients.
  • To assess the effectiveness of CR as a secondary prevention strategy for cardiovascular events.

Main Methods:

  • Systematic review and meta-analysis of 12 studies, including randomized controlled trials and cohort studies.
  • Analysis of data on all-cause mortality, International Classification of Functioning, Disability and Health (ICF) domains, and other relevant patient outcomes.

Main Results:

  • CR programs were found to be effective in reducing all-cause mortality (RR=0.74).
  • Significant favorable effects of CR were observed in the ICF domains of body functions (SMD=0.55).
  • CR improves functional status and lowers mortality rates in patients with cardiovascular diseases.

Conclusions:

  • CR programs are a significant and effective component of secondary CVD prevention.
  • There is a need for improved global implementation and standardization of CR programs to increase patient access and adherence.
  • Addressing suboptimal CR program implementation is essential for maximizing patient benefits.

Related Concept Videos

Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
737
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
386
Exercise and Cardiac Output01:17

Exercise and Cardiac Output

Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
923
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
316
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
12